Drug Trial Radar · NCT04936035
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension
Last checked: Nov 20, 2026Latest source record: Dec 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
394
Actual
Start
Jul 7, 2021
Primary completion
Apr 4, 2023
Study completion Dec 5, 2024
Sponsor
- Lead sponsor
- Alnylam PharmaceuticalsAlnylam Pharmaceuticals (ALNY)
- Sponsor type
- Industry
- First posted
- Jun 23, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effect of ALN-AGT01 on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of ALN-AGT01.
Conditions
- Hypertension
Interventions
PlaceboDrug
Placebo administered by SC injection
ALN-AGT01Drug
ALN-AGT01 administered by SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline at Month 3 in 24-hour Mean SBP Assessed by ABPMTime frame: Baseline and Month 3
Locations
75 sites in 5 countries. Site status is shown where the registry gives one.
Clinical Trial Site
Birmingham, Alabama
Clinical Trial Site
Tempe, Arizona
Clinical Trial Site
Tempe, Arizona
Clinical Trial Site
Beverly Hills, California
Clinical Trial Site
La Mesa, California
Clinical Trial Site
Los Angeles, California
Clinical Trial Site
San Diego, California
Clinical Trial Site
South Gate, California
Clinical Trial Site
Vista, California
Clinical Trial Site
Washington D.C., District of Columbia
Clinical Trial Site
Clearwater, Florida
Clinical Trial Site
Coral Gables, Florida
Clinical Trial Site
Fleming Island, Florida
Clinical Trial Site
Hollywood, Florida
Clinical Trial Site
Hollywood, Florida
Clinical Trial Site
Inverness, Florida
Clinical Trial Site
Jacksonville, Florida
Clinical Trial Site
Jacksonville, Florida
Clinical Trial Site
Jacksonville, Florida
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Naples, Florida
Clinical Trial Site
Orlando, Florida
Clinical Trial Site
Acworth, Georgia
Clinical Trial Site
Columbus, Georgia
Clinical Trial Site
Fayetteville, Georgia
Clinical Trial Site
Macon, Georgia
Clinical Trial Site
Champaign, Illinois
Clinical Trial Site
Valparaiso, Indiana
Clinical Trial Site
West Des Moines, Iowa
Clinical Trial Site
Lake Charles, Louisiana
Clinical Trial Site
New Orleans, Louisiana
Clinical Trial Site
Prairieville, Louisiana
Clinical Trial Site
Baltimore, Maryland
Clinical Trial Site
Jackson, Mississippi
Clinical Trial Site
Jefferson City, Missouri
Clinical Trial Site
Las Vegas, Nevada
Clinical Trial Site
New York, New York
Clinical Trial Site
The Bronx, New York
Clinical Trial Site
Greensboro, North Carolina
Showing 40 of 75 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.